Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
2006 · Nature Clinical Practice Oncology · 913 citations
https://doi.org/10.1038/ncponc0509
R
Rita Nahta
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
7.8K
Citations
40
h-index
61
i10-index
Rita Nahta is an academic researcher. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research & Cancer, Hypoxia, and Metabolism. The author has an h-index of 40, co-authored 88 publications.
Papers by this author
worksInsulin-like Growth Factor-I Receptor/Human Epidermal Growth Factor Receptor 2 Heterodimerization Contributes to Trastuzumab Resistance of Breast Cancer Cells
2005 · Cancer Research · 795 citations
https://doi.org/10.1158/0008-5472.can-04-3841
Herceptin: mechanisms of action and resistance
2005 · Cancer Letters · 440 citations
https://doi.org/10.1016/j.canlet.2005.01.041
HER2 therapy: Molecular mechanisms of trastuzumab resistance
2006 · Breast Cancer Research · 428 citations
https://doi.org/10.1186/bcr1612
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
2015 · Carcinogenesis · 314 citations
https://doi.org/10.1093/carcin/bgv039
Designing a broad-spectrum integrative approach for cancer prevention and treatment
2015 · Seminars in Cancer Biology · 294 citations
https://doi.org/10.1016/j.semcancer.2015.09.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat